Aldolase predicts subsequent myopathy occurrence in systemic sclerosis

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Tolédano, Cécile ^a   Gain, Murielle ^a   Kettaneh, Adrien ^a   Baudin, Bruno ^b   Johanet, Catherine ^c   Chérin, Patrick ^a   Rivière, Sébastien ^a   Cabane, Jean ^a   Tiev, Kiet P ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Biochemistry Laboratory   (France)

^c Immunology Laboratory   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTEMIC SCLEROSIS;

EID: 84865176917     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3888     Document Type: Article

References (25)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009, 360:1989-2003. 10.1056/NEJMra0806188, 19420368.
2. Follansbee WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993, 125:194-203. 10.1016/0002-8703(93)90075-K, 8417518.
3. Ranque B, Authier FJ, Berezne A, Guillevin L, Mouthon L. Systemic sclerosis-associated myopathy. Ann N Y Acad Sci 2007, 1108:268-282. 10.1196/annals.1422.029, 17899625.
4. Medsger TA, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1968, 11:554-568. 10.1002/art.1780110405, 5676926.
5. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscular Disord 2004, 14:337-345.
6. Ranque B, Authier FJ, Le-Guern V, Pagnoux C, Berezne A, Allanore Y, Launay D, Hachulla E, Kahan A, Cabane J, Gherardi R, Guillevin L, Mouthon L. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis 2009, 68:1474-1477. 10.1136/ard.2008.095919, 19054827.
7. Cherin P, Herson S, Weschler B, Piette JC, Bletry O, Ziza JM, Degennes C, Godeau P. Intravenous immunoglobulin in polymyositis and dermatomyositis. Lancet 1990, 336:518.
8. Cherin P, Herson S, Weschler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients. Am J Med 1991, 91:162-168. 10.1016/0002-9343(91)90009-M, 1714235.
9. Rider LG, Miller FW. Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol 1995, 2:1-9. 170091, 7719899.
10. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590. 10.1002/art.1780230510, 7378088.
11. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
12. Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. 1976, London: Her Majesty's Stationary Office.
13. Paternostro-Sluga T, Grim-Stieger M, Posch M, Schuhfried O, Vacariu G, Mittermaier C, Bittner C, Fialka-Moser V. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 2008, 40:665-671. 10.2340/16501977-0235, 19020701.
14. Kendall FP, McCreary EK, Provance PG. Muscles: Testing and Function. 1993, Baltimore: Williams and Wilkins, 4.
15. Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2010, 62:465-472.
16. Clements PJ, Furst DE, Campion DS, Bohan A, Harris R, Levy J, Paulus HE. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 1978, 21:62-71. 10.1002/art.1780210111, 623695.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407. 10.1056/NEJM197502202920807, 1089199.
18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347. 10.1056/NEJM197502132920706, 1090839.
19. Hanke K, Bruckner CS, Dahnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 2009, 11:R22. 10.1186/ar2614, 2688254, 19220911.
20. Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 1992, 35:1211-1217. 10.1002/art.1780351014, 1418007.
21. Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, Treadwell E, Tan EM. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 1984, 4:40-44. 10.1007/BF00915286, 6699138.
22. Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, Buslau M, Worm M, Blank N, Hein R, Müller-Ladner U, Kuhn A, Sunderkötter C, Juche A, Pfeiffer C, Fiehn C, Sticherling M, Lehmann P, Stadler R, Schulze-Lohoff E, Seitz C, Foeldvari I, Krieg T, Genth E, Hunzelmann N. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011, 13:R172. 10.1186/ar3495, 3308107, 22018289.
23. Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F. Long-term outcome of patients with polymyositis/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 2010, 162:337-344. 10.1111/j.1365-2133.2009.09484.x, 19845665.
24. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969, 46:428-440. 10.1016/0002-9343(69)90044-8, 5780367.
25. Avouac J, Airo P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 2010, 37:608-614. 10.3899/jrheum.090815, 20110522.